Dr. Dougan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
Boston, MA 11794Phone+1 617-724-6007
Education & Training
Massachusetts General HospitalFellowship, Gastroenterology, 2013 - 2015- Massachusetts General HospitalResidency, Internal Medicine, 2011 - 2014
Harvard Medical SchoolClass of 2011
Certifications & Licensure
MA State Medical License 2011 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis Start of enrollment: 2020 Aug 31
Publications & Presentations
PubMed
- 301 citationsDe novo design of potent and selective mimics of IL-2 and IL-15Daniel-Adriano Silva, Shawn Yu, Umut Ulge, Jamie B. Spangler, Kevin Jude
Nature. 2019-01-09 - 571 citationsSARS-CoV-2 viral load is associated with increased disease severity and mortality.Jesse Fajnzylber, James Regan, Kendyll Coxen, Heather Corry, Colline Wong
Nature Communications. 2020-10-30 - 23 citationsImmune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data.Kerry L. Reynolds, Shaily Arora, Ravikumar Komandur Elayavilli, William C Louv, Teilo H Schaller
Journal for Immunotherapy of Cancer. 2021-07-01
Journal Articles
- Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHsMichael Dougan, MD, Clinical Cancer Research
Press Mentions
New Weapons Against Cancer: Millions of Bacteria Programmed to KillJuly 5th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
